Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Christophe SchmittLaura BrockwellMylène GiraudonMauro ZucchettoLisa ChristBettina BannertThomas DaikelerPeter M VilligerPublished in: Arthritis research & therapy (2022)
ClinicalTrials.gov , NCT03923738.